MEDIORG

Medicamen Organics Share Price

₹52.95 -0.85 (-1.58%)

21 Nov, 2024 14:44

SIP TrendupStart SIP in MEDIORG

Start SIP

Performance

  • Low
  • ₹53
  • High
  • ₹53
  • 52 Week Low
  • ₹51
  • 52 Week High
  • ₹159
  • Open Price₹53
  • Previous Close₹54
  • Volume10,000

Investment Returns

  • Over 1 Month -4.85%
  • Over 3 Month -21.15%
  • Over 6 Month + 55.74%
  • Over 1 Year + 55.74%
SIP Lightning

Smart Investing Starts Here Start SIP with Medicamen Organics for Steady Growth!

Invest Now

Medicamen Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 62
  • P/B Ratio
  • 4.1
  • Average True Range
  • 2.23
  • EPS
  • 2.05
  • Dividend Yield
  • 0
  • MACD Signal
  • -2.54
  • RSI
  • 43.08
  • MFI
  • 37.84

Medicamen Organics Financials

Medicamen Organics Technicals

EMA & SMA

Current Price
₹52.95
-0.85 (-1.58%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹54.76
  • 50 Day
  • ₹62.59
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

53.27 Pivot Speed
  • R3 55.93
  • R2 54.87
  • R1 54.33
  • S1 52.73
  • S2 51.67
  • S3 51.13

What's your outlook on Medicamen Organics?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Medicamen Organics Ltd has an operating revenue of Rs. 68.39 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 13% is healthy, ROE of 15% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 33 indicates it belongs to a strong industry group of Medical-Products and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Medicamen Organics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results & Others To consider other business matters.

Medicamen Organics F&O

Medicamen Organics Shareholding Pattern

59.69%
0.07%
0.14%
0%
28.27%
11.83%

About Medicamen Organics

  • NSE Symbol
  • MEDIORG
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Bal Kishan Gupta
  • ISIN
  • INE0PE401018

Similar Stocks to Medicamen Organics

Medicamen Organics FAQs

Medicamen Organics share price is ₹52 As on 21 November, 2024 | 14:30

The Market Cap of Medicamen Organics is ₹62 Cr As on 21 November, 2024 | 14:30

The P/E ratio of Medicamen Organics is As on 21 November, 2024 | 14:30

The PB ratio of Medicamen Organics is 4.1 As on 21 November, 2024 | 14:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23